Maxigen Biotech (TPE:1783) Total Debt per Share : NT$0.00 (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Total Debt per Share?

NT$0.00 (As of Mar. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Maxigen Biotech's Total Debt Per Share for the quarter that ended in Mar. 2025 was NT$0.00.

Maxigen Biotech Total Debt per Share Historical Data

The historical data trend for Maxigen Biotech's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Total Debt per Share Chart

Maxigen Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Debt per Share

Get a 7-Day Free Trial

0.15

0.11

Maxigen Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Debt per Share	Get a 7-Day Free Trial															-	0.01	-	-	-

Maxigen Biotech Total Debt per Share Calculation

Maxigen Biotech's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.0	+	0.0)	/	89.2
	=	0.00

Maxigen Biotech's Total Debt Per Share for the quarter that ended in Mar. 2025 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.0	+	0.0)	/	89.2
	=	0.00

Maxigen Biotech Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333

Website

https://www.mbi-bio.com

Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.

Maxigen Biotech Headlines

No Headlines